BIIB-042

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameBIIB-042

Drug Alias NameBIIB-042

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGamma-secretase inhibitors

TargetsGamma-secretase

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiogen Idec

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiogen Idec

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A